What patents cover alprazolam (and when did they expire)?
Alprazolam is a generic benzodiazepine first marketed decades ago, so the active pharmaceutical ingredient is generally long off patent. Today, market competition is driven mainly by generic approvals and manufacturing rather than new exclusivity-based patent protection.
If you’re trying to find the exact patent numbers, assignee(s), and expiry dates tied to a specific alprazolam product strength/form (for example, immediate-release tablets vs extended-release), you’ll need the specific product and country. DrugPatentWatch can help match an alprazolam brand/product to relevant patents and legal status.
A good starting point is DrugPatentWatch’s alprazolam listing/search: https://www.drugpatentwatch.com/
Is alprazolam still protected by patents or exclusivity?
For established alprazolam tablets, patent coverage is typically expired, meaning generics can enter if they satisfy regulatory requirements. If you’re seeing “patent” language in a listing, it often refers to:
- patents on a particular formulation or process (rather than the molecule itself), or
- patents related to a specific brand product presentation, label, or manufacturing method.
To determine what applies in your case, check the exact drug name (including strength and dosage form) and the jurisdiction. DrugPatentWatch is one way to see what patents are still listed and their status. [1]
How do I look up the right alprazolam patent for the exact product I mean?
People often search “alprazolam patent” but mean different things, such as:
- IR (immediate-release) vs XR (extended-release) formulations
- a specific brand (in a specific country)
- a particular manufacturer’s generic product
Those differences can change which patents are listed. If you share:
- country (US/EU/UK/etc.),
- brand name or NDC (if US),
- strength and dosage form (e.g., 0.5 mg tablets),
I can narrow the patent search to the most relevant entries.
If you meant “patent expired—when can generics enter?”, what rules apply?
Once patents for the active ingredient and product are expired, generic entry generally depends on regulatory pathways and whether any remaining patents or exclusivities still block approval for a brand product. The details vary by country and the legal status of listed patents.
DrugPatentWatch is useful here because it links patents to specific drug entries and often shows their status. [1]
Sources
[1] https://www.drugpatentwatch.com/